Why These 5 Stocks Are on the Move on Wednesday

2. Biogen Inc. (NASDAQ:BIIB) is around 1.6% in the red after the news site STAT indicated that Biogen Inc. (NASDAQ:BIIB)’s Aduhelm could be potentially be launching slower than some expectations. Biogen Inc. (NASDAQ:BIIB)’Aduhelm is the company’s newly approved Alzheimer’s disease therapy.

Of the around 873 elite funds we track, 67 were long Biogen Inc. (NASDAQ:BIIB) in Q2.